Journal of Surgery Concepts & Practice >

2021 , Vol. 26 >Issue 01: 76 - 78

DOI: https://doi.org/10.16139/j.1007-9610.2021.01.016

Review

Exosomes research in pathophysiology of peritoneal metastatic gastric cancer

Expand

Received date: 2020-09-09

  Online published: 2022-07-28

Fold

Cite this article

LIU Xuanyu, CHEN Lei . Exosomes research in pathophysiology of peritoneal metastatic gastric cancer[J]. Journal of Surgery Concepts & Practice, 2021 , 26(01) : 76 -78 . DOI: 10.16139/j.1007-9610.2021.01.016

References

[1] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5):E359-E386.
[2] Wang Z, Chen JQ, Liu JL, et al. Issues on peritoneal metastasis of gastric cancer: an update[J]. World J Surg Oncol, 2019, 17(1):215.
[3] Kanda M, Kodera Y. Molecular mechanisms of peritoneal dissemination in gastric cancer[J]. World J Gastroenterol, 2016, 22(30):6829-6840.
[4] Isola AL, Chen S. Exosomes: the messengers of health and disease[J]. Curr Neuropharmacol, 2017, 15(1):157-165.
[5] van Dommelen SM, Vader P, Lakhal S, et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery[J]. J Control Release, 2012, 161(2):635-644.
[6] Han L, Lam EW, Sun Y. Extracellular vesicles in the tumor microenvironment: old stories, but new tales[J]. Mol Cancer, 2019, 18(1):59.
[7] Yashiro M, Chung YS, Nishimura S, et al. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination[J]. Cancer, 1996, 77(8 Suppl):1668-1675.
[8] Kusamura S, Baratti D, Zaffaroni N, et al. Pathophysiology and biology of peritoneal carcinomatosis[J]. World J Gastrointest Oncol, 2010, 2(1):12-18.
[9] Huang J, Shen M, Yan M, et al. Exosome-mediated transfer of miR-1290 promotes cell proliferation and invasion in gastric cancer via NKD1[J]. Acta Biochim Biophys Sin(Shanghai), 2019, 51(9):900-907.
[10] Pan L, Liang W, Fu M, et al. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression[J]. J Cancer Res Clin Oncol, 2017, 143(6):991-1004.
[11] Qu JL, Qu XJ, Zhao MF, et al. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation[J]. Dig Liver Dis, 2009, 41(12):875-880.
[12] Mukai S, Oue N, Oshima T, et al. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer[J]. J Pathol, 2017, 243(1):100-110.
[13] Kitayama J, Yamaguchi H, Ishigami H, et al. Intraperitoneal mesenchymal cells promote the development of peritoneal metastasis partly by supporting long migration of disseminated tumor cells[J]. Plos One, 2016, 11(5):e0154542.
[14] Miyake S, Kitajima Y, Nakamura J, et al. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer[J]. Int J Oncol, 2013, 43(5):1431-1440.
[15] Panigrahi GK, Praharaj PP, Peak TC, et al. Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells[J]. Sci Rep, 2018, 8(1):3853.
[16] Zhihua Y, Yulin T, Yibo W, et al. Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer[J]. Cancer Sci, 2019, 110(8):2368-2377.
[17] Chen J, Xu R, Xia J, et al. Aspirin inhibits hypoxia-mediated lung cancer cell stemness and exosome function[J]. Pathol Res Pract, 2019, 215(6):152379.
[18] Xu Y, Jin X, Huang Y, et al. Inhibition of peritoneal metastasis of human gastric cancer cells by dextran sulphate through the reduction in HIF-1 α and ITG β 1 expression[J]. Oncol Rep, 2016, 35(5):2624-2634.
[19] Wei M, Yang T, Chen X, et al. Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells[J]. Oncotarget, 2017, 8(26):42262-42271.
[20] Najgebauer H, Jarnuczak AF, Varro A, et al. Integrative omic profiling reveals unique hypoxia induced signatures in gastric cancer associated myofibroblasts[J]. Cancers (Basel), 2019, 11(2):263.
[21] Tanaka M, Kuriyama S, Itoh G, et al. Mesothelial cells create a novel tissue niche that facilitates gastric cancer invasion[J]. Cancer Res, 2017, 77(3):684-695.
[22] Sluiter N, de Cuba E, Kwakman R, et al. Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options[J]. Clin Exp Metastasis, 2016, 33(5):401-416.
[23] Du J, Liang Y, Li J, et al. Gastric cancer cell-derived exosomal microRNA-23a promotes angiogenesis by targeting PTEN[J]. Front Oncol, 2020, 10:326.
[24] Zhang S, Zhang R, Xu R, et al. MicroRNA-574-5p in gastric cancer cells promotes angiogenesis by targeting protein tyrosine phosphatase non-receptor type 3 (PTPN3)[J]. Gene, 2020, 733:144383.
[25] Li Y, Wu ZZ, Yuan J, et al. Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis[J]. Cancer Let, 2017, 395:31-44.
[26] Zhou Z, Zhang H, Deng T, et al. Exosomes carrying microRNA-155 target forkhead box O3 of endothelial cells and promote angiogenesis in gastric cancer[J]. Mol Ther Oncolytics, 2019, 15:223-233.
[27] Zhang H, Deng T, Liu R, et al. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis[J]. Nat Commun, 2017, 8:15016.
[28] Zhao K, Wang Z, Li X, et al. Exosome-mediated transfer of CLIC1 contributes to the vincristine-resistance in gastric cancer[J]. Mol Cell Biochem, 2019, 462(1-2):97-105.
[29] Wang J, Lv B, Su Y, et al. Exosome-mediated transfer of lncRNA hottip promotes cisplatin resistance in gastric cancer cells by regulating HMGA1/MIR-218 axis[J]. Onco Targets Ther, 2019, 12:11325-11338.
Options
Outlines

/

〈 〉